Echopoint Medical, a cardiovascular diagnostic technology company and a UCL spinout, has secured £4.2 million in Series A funding round. The investment will support the company's flagship iKOr system through FDA approval for the US market. The iKOr system, developed following a successful clinical trial at St Bartholomew’s Hospital, aims to improve coronary flow assessments, particularly benefiting women with angina.

The Series A funding round was led by current investors, including UCL Technology Fund, managed by AlbionVC, and Parkwalk Advisors, supported by UCL Business.

International legal practice Osborne Clarke advised AlbionVC, the team was led by venture and growth capital partner Justin Starling who was supported by senior associate Magnus Williams.

Osborne Clarke's international venture capital team is a leading practice for companies operating in tech-enabled industries. From start-up through venture financing and the growth journey beyond, whether continuing to sale, IPO or international expansion, the team has an outstanding track record advising businesses, entrepreneurs and investors that are driving innovation. Osborne Clarke's dedicated resource centre, OC Ventures, brings together experts from across our international network to deliver a seamless service to clients throughout the ventures ecosystem.

Follow
Corporate communications and press contacts
If you are a journalist and would like comment or background from our legal experts, we can help. Our team will put you in touch with the best person. View a full list of our international press contacts by jurisdiction here.

Connect with one of our experts